Cardiology
ARC-HBR Criteria for High Bleeding Risk in PCI
Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria. HBR = 1 major OR ≥ 2 minor criteria. Guides DAPT duration post-PCI.
References
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- DAPT Score · Coronary Artery Disease
- Mehran Score for Post-PCI Contrast Nephropathy · Coronary Artery Disease
- Canadian Cardiovascular Society (CCS) Angina Grading · Coronary Artery Disease
- Duke Treadmill Score · Coronary Artery Disease
- PRECISE-DAPT Score for Bleeding on DAPT · Coronary Artery Disease
- SYNTAX Score for Coronary Artery Disease · Coronary Artery Disease
Drugs
- Palivizumab · RSV Prophylaxis — Monthly Monoclonal Antibody (High-Risk Infants)
- Hydroxocobalamin (High-Dose — Cyanide Antidote) · Cyanide Antidote (Vitamin B12 Precursor at High Dose)
- Ticagrelor · Antiplatelet
- Prasugrel · Antiplatelet
- Colchicine (Pericarditis / Post-MI Inflammation) · Pericarditis / Coronary Inflammation
- Aspirin (Antiplatelet — ACS/PCI) · Antiplatelet / ACS
Pathways
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.